Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
|
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [41] Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases
    Akkaya, C.
    Kaya, B.
    Kotan, Z.
    Sarandol, A.
    Ersoy, C.
    Kirli, S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) : 723 - 726
  • [42] Hyperprolactinemia in postmenopausal women
    Maor, Y
    Berezin, M
    FERTILITY AND STERILITY, 1997, 67 (04) : 693 - 696
  • [43] HYPERPROLACTINEMIA IN ZIMBABWEAN WOMEN
    KASULE, J
    CHIMBIRA, THK
    CENTRAL AFRICAN JOURNAL OF MEDICINE, 1987, 33 (07) : 173 - 178
  • [44] Hyperprolactinemia secondary to prolactinoma and systemic lupus erythematosus: Probably association a major organ
    Alcala, M
    Vera-Lastra, O
    Walker, S
    Jara, L
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 240 - 240
  • [45] PROLACTINOMA IN WOMEN - THERAPEUTIC RESULTS
    BEAUREGARD, H
    VANCAMPENHOUT, J
    RASIO, E
    SOMMA, M
    NEUROCHIRURGIE, 1981, 27 : 83 - 90
  • [46] Evaluation of Hyperandrogenemia in Women with Prolactinoma
    Unal, Mehmet Cagri
    Karaca, Zuleyha
    Unluhizarci, Kursad
    Kelestemur, Fahrettin
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 24 (01) : 55 - 62
  • [47] HYPERPROLACTINEMIA AND STERILITY IN WOMEN
    JUNKERMANN, H
    JUNKERMANN, I
    HOLST, TV
    RUNNEBAUM, B
    ARCHIVES OF GYNECOLOGY, 1979, 228 (1-4): : 595 - 596
  • [48] Clinical effectiveness of the various approaches for infertility treatment in women with PCOS and hyperprolactinemia
    Gladchuk IZ
    Semenyuta OM
    Onyshchenko YV
    中国现代医学杂志, 2014, (16) : 1 - 4
  • [49] The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients
    Huan, Cheng
    Cui, Guihua
    Ren, Zongming
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (02) : 713 - 718
  • [50] SPONTANEOUS RESOLUTION OF HYPERPROLACTINEMIA RESULTING FROM BIOPSY-PROVEN SELECTIVE AUTOABLATION OF A PROLACTINOMA
    KRCEK, JP
    MACRAE, E
    CORENBLUM, B
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (02) : 226 - 226